Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dusama (Budesonide) HFA MDI vs Pulmicort (Budesonide) Turbuhaler in Mild to Moderate Chinese Asthma Patients
NCT05152355Phase 4Completed
- Sponsor
- Intech Biopharm Corporation
- Start
- Apr 2019
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of budesonide in asthma (2 arms), sponsored by Intech Biopharm Corporation. Primary endpoint: Forced Expiratory Volume in 1 second at Week 4. Started Apr 2019; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT05152355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05152355.